Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
NCT00543244
·
clinicaltrials.gov ↗
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis C
Interventions
DRUG:
Pegylated interferon alfa and ribavirin
Sponsor
National Taiwan University Hospital
Collaborators
[object Object]